
The top 5 OncLive TV videos of the week cover insights in NSCLC, gynecologic cancers, CRC, multiple myeloma, and NMIBC.
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
The FDA approved atezolizumab (Tecentriq) plus mFOLFOX6 as adjuvant treatment for patients with stage III mismatch repair–deficient (dMMR) colon cancer, based on findings from the phase 3 ATOMIC trial (NCT02912559). What was the 3-year disease-free survival (DFS) rate in the atezolizumab arm?






